FDA Inspection 1174494 — Regenerative Biologics, Inc.
The FDA completed an inspection of Regenerative Biologics, Inc. on Jul 14, 2022 in Bradenton, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Bradenton, FL (United States)